Erratum: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: Subset analyses of the AVAGAST study and the ToGA study (Gastric Cancer DOI: 10.1007/s10120-012-0167-0)

Kensei Yamaguchi; Akira Sawaki; Toshihiko Doi; Taroh Satoh; Yasuhide Yamada; Yasushi Omuro; Tomohiro Nishina; Narikazu Boku; Keisho Chin; Yasuo Hamamoto; Hiroya Takiuchi; Yoshito Komatsu; Shigehira Saji; Wasaburo Koizumi; Yoshinori Miyata; Atsushi Sato; Eishi Baba; Takao Tamura; Takashi Abe; Atsushi Ohtsu

doi:10.1007/s10120-012-0205-y

Erratum: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: Subset analyses of the AVAGAST study and the ToGA study (Gastric Cancer DOI: 10.1007/s10120-012-0167-0)

Kensei Yamaguchi
, Akira Sawaki
, Toshihiko Doi
, Taroh Satoh
, Yasuhide Yamada
, Yasushi Omuro
, Tomohiro Nishina
, Narikazu Boku
, Keisho Chin
, Yasuo Hamamoto
, Hiroya Takiuchi
, Yoshito Komatsu
, Shigehira Saji
, Wasaburo Koizumi
, Yoshinori Miyata
, Atsushi Sato
, Eishi Baba
, Takao Tamura
, Takashi Abe
, Atsushi Ohtsu

Gastroenterology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	183-184
Number of pages	2
Journal	Gastric Cancer
Volume	16
Issue number	2
DOIs	https://doi.org/10.1007/s10120-012-0205-y
Publication status	Published - 04-2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Oncology
Gastroenterology
Cancer Research

Access to Document

10.1007/s10120-012-0205-y

Cite this

Yamaguchi, K., Sawaki, A., Doi, T., Satoh, T., Yamada, Y., Omuro, Y., Nishina, T., Boku, N., Chin, K., Hamamoto, Y., Takiuchi, H., Komatsu, Y., Saji, S., Koizumi, W., Miyata, Y., Sato, A., Baba, E., Tamura, T., Abe, T., & Ohtsu, A. (2013). Erratum: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: Subset analyses of the AVAGAST study and the ToGA study (Gastric Cancer DOI: 10.1007/s10120-012-0167-0). Gastric Cancer, 16(2), 183-184. https://doi.org/10.1007/s10120-012-0205-y

@article{6d2c794d81e745a7ab50af343b3d6c53,

title = "Erratum: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: Subset analyses of the AVAGAST study and the ToGA study (Gastric Cancer DOI: 10.1007/s10120-012-0167-0)",

author = "Kensei Yamaguchi and Akira Sawaki and Toshihiko Doi and Taroh Satoh and Yasuhide Yamada and Yasushi Omuro and Tomohiro Nishina and Narikazu Boku and Keisho Chin and Yasuo Hamamoto and Hiroya Takiuchi and Yoshito Komatsu and Shigehira Saji and Wasaburo Koizumi and Yoshinori Miyata and Atsushi Sato and Eishi Baba and Takao Tamura and Takashi Abe and Atsushi Ohtsu",

year = "2013",

month = apr,

doi = "10.1007/s10120-012-0205-y",

language = "English",

volume = "16",

pages = "183--184",

journal = "Gastric Cancer",

issn = "1436-3291",

publisher = "Springer",

number = "2",

}

Yamaguchi, K, Sawaki, A, Doi, T, Satoh, T, Yamada, Y, Omuro, Y, Nishina, T, Boku, N, Chin, K, Hamamoto, Y, Takiuchi, H, Komatsu, Y, Saji, S, Koizumi, W, Miyata, Y, Sato, A, Baba, E, Tamura, T, Abe, T & Ohtsu, A 2013, 'Erratum: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: Subset analyses of the AVAGAST study and the ToGA study (Gastric Cancer DOI: 10.1007/s10120-012-0167-0)', Gastric Cancer, vol. 16, no. 2, pp. 183-184. https://doi.org/10.1007/s10120-012-0205-y

Erratum: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: Subset analyses of the AVAGAST study and the ToGA study (Gastric Cancer DOI: 10.1007/s10120-012-0167-0). / Yamaguchi, Kensei; Sawaki, Akira; Doi, Toshihiko et al.
In: Gastric Cancer, Vol. 16, No. 2, 04.2013, p. 183-184.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Erratum

T2 - Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: Subset analyses of the AVAGAST study and the ToGA study (Gastric Cancer DOI: 10.1007/s10120-012-0167-0)

AU - Yamaguchi, Kensei

AU - Sawaki, Akira

AU - Doi, Toshihiko

AU - Satoh, Taroh

AU - Yamada, Yasuhide

AU - Omuro, Yasushi

AU - Nishina, Tomohiro

AU - Boku, Narikazu

AU - Chin, Keisho

AU - Hamamoto, Yasuo

AU - Takiuchi, Hiroya

AU - Komatsu, Yoshito

AU - Saji, Shigehira

AU - Koizumi, Wasaburo

AU - Miyata, Yoshinori

AU - Sato, Atsushi

AU - Baba, Eishi

AU - Tamura, Takao

AU - Abe, Takashi

AU - Ohtsu, Atsushi

PY - 2013/4

Y1 - 2013/4

UR - https://www.scopus.com/pages/publications/84880701277

UR - https://www.scopus.com/pages/publications/84880701277#tab=citedBy

U2 - 10.1007/s10120-012-0205-y

DO - 10.1007/s10120-012-0205-y

M3 - Comment/debate

AN - SCOPUS:84880701277

SN - 1436-3291

VL - 16

SP - 183

EP - 184

JO - Gastric Cancer

JF - Gastric Cancer

IS - 2

ER -

Erratum: Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: Subset analyses of the AVAGAST study and the ToGA study (Gastric Cancer DOI: 10.1007/s10120-012-0167-0)

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this